Study of Cardioplegia in Cardiac Surgery Due to Congenital Heart Malformation in Children

Dr. Franz Köhler Chemie

Status and phase: Suspended; Phase 2

Conditions: Congenital Heart Malformations

Treatments: Drug: heart will be treated with Custodiol-N; Drug: heart will be treated with Custodiol

Study type: Interventional

Funder types: Industry

Identifiers

NCT07381530

CL-N-CP-Paed-II/09/19

Details and patient eligibility

About

The objective of this investigation is to compare the safety and cardioprotective effects of Custodiol and Custodiol-N in children undergoing cardiac surgery with cardiopulmonary bypass (CPB) due to congenital heart malformation. All endpoint timings refer to the opening of the aortic cross clamp (t=0)

Full description

Efficacy of Custodiol-N and its safety is being thoroughly studied in adults undergoing solid organ transplantation. In addition, safety data are available from its use as cardioplegic solution in approximately 400 adults. Paediatric cardiac surgery nearly exclusively addresses congenital heart disease (CHD). CHD comprises a wide variety of congenital malformations of structures of the heart or the great vessels. The causes may be genetic, environmental or both. The objective of this investigation is to compare the safety and cardioprotective effects of Custodiol and Custodiol-N in children undergoing cardiac surgery with cardiopulmonary bypass (CPB) due to congenital heart malformation.

Enrollment: 100 estimated patients

Sex: All

Ages: 24 hours to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age from birth to less than 18 years of age
• congenital heart surgery with cardiopulmonary bypass and cardioplegia
• written informed consent of the patients and/ or their legal guardians (must be available before enrolment in the study)
• Ability of the legal guardians to understand character and individual consequences of the clinical trial

Exclusion criteria

• Patients who have participated within 30 days or are still participating in any other interventional study
• History of severe organic (e.g. liver or kidney) disease other than concerning the heart
• History of psychiatric disease
• Pregnancy and lactation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

Custodiol-N

Experimental group

Description:

organ will be perfused with Custodiol-N solution

Treatment:

Drug: heart will be treated with Custodiol-N

Custodiol

Active Comparator group

Description:

organ will be perfused with Custodiol solution

Treatment:

Drug: heart will be treated with Custodiol